KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Non-Current Assets (2018 - 2025)

ClearPoint Neuro's Non-Current Assets history spans 13 years, with the latest figure at $9.0 million for Q3 2025.

  • For Q3 2025, Non-Current Assets rose 53.98% year-over-year to $9.0 million; the TTM value through Sep 2025 reached $29.6 million, up 21.08%, while the annual FY2024 figure was $5.8 million, 10.22% down from the prior year.
  • Non-Current Assets for Q3 2025 was $9.0 million at ClearPoint Neuro, up from $8.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $9.0 million in Q3 2025 and bottomed at $3.6 million in Q2 2022.
  • The 5-year median for Non-Current Assets is $5.8 million (2024), against an average of $5.4 million.
  • The largest annual shift saw Non-Current Assets skyrocketed 124.51% in 2021 before it dropped 13.16% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $3.7 million in 2021, then increased by 16.83% to $4.3 million in 2022, then skyrocketed by 50.56% to $6.5 million in 2023, then decreased by 10.22% to $5.8 million in 2024, then skyrocketed by 54.96% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Non-Current Assets are $9.0 million (Q3 2025), $8.9 million (Q2 2025), and $5.9 million (Q1 2025).